A Constructive Algorithm for Wavelet Neural Networks

Jinhua Xu,D. Ho

DOI: https://doi.org/10.1007/11539087_97

2005-08-27

Abstract:

What problem does this paper attempt to address?

Injectable, porous, biohybrid hydrogels incorporating decellularized tissue components for soft tissue applications.

Yang Zhu,Sato Hideyoshi,Hongbin Jiang,Yasumoto Matsumura,Jenna L Dziki,Samuel T LoPresti,Luai Huleihel,Gabriela N F Faria,Leah C Fuhrman,Ricardo Lodono,Stephen F Badylak,William R Wagner

DOI: https://doi.org/10.1016/j.actbio.2018.04.003

IF: 10.633

2018-01-01

Acta Biomaterialia

Abstract:Biodegradable injectable hydrogels have been extensively studied and evaluated in various medical applications such as for bulking agents, drug delivery reservoirs, temporary barriers, adhesives, and cell delivery matrices. Where injectable hydrogels are intended to facilitate a healing response, it may be desirable to encourage rapid cellular infiltration into the hydrogel volume from the tissue surrounding the injection site. In this study, we developed a platform technique to rapidly form pores in a thermally responsive injectable hydrogel, poly(NIPAAm-co-VP-co-MAPLA) by using mannitol particles as porogens. In a rat hindlimb muscle injection model, hydrogels incorporating porosity had significantly accelerated cellular infiltration. To influence the inflammatory response to the injected hydrogel, enzymatically digested urinary bladder matrix (UBM) was mixed with the solubilized hydrogel. The presence of UBM was associated with greater polarization of the recruited macrophage population to the M2 phenotype, indicating a more constructive foreign body response. The hybrid hydrogel positively affected the wound healing outcomes of defects in rabbit adipose tissue with negligible inflammation and fibrosis, whereas scar formation and chronic inflammation were observed with autotransplantation and in saline injected groups. These results demonstrate the value of combining the effects of promoting cell infiltration and mediating the foreign body response for improved biomaterials options soft tissue defect filling applications. STATEMENT OF SIGNIFICANCE:Our objective was to develop a fabrication process to create porous injectable hydrogels incorporating decellularized tissue digest material. This new hydrogel material was expected to exhibit faster cellular infiltration and a greater extent of pro-M2 macrophage polarization compared to control groups not incorporating each of the functional components. Poly(NIPAAm-co-VP-co-MAPLA) was chosen as the representative thermoresponsive hydrogel, and mannitol particles and digested urinary bladder matrix (UBM) were selected as the porogen and the bioactive decellularized material components respectively. In rat hindlimb intramuscular injection models, this new hydrogel material induced more rapid cellular infiltration and a greater extent of M2 macrophage polarization compared to control groups not incorporating all of the functional components. The hybrid hydrogel positively affected the wound healing outcomes of defects in rabbit adipose tissue with negligible inflammation and fibrosis, whereas scar formation and chronic inflammation were observed with autotransplantation and in saline injected groups. The methodology of this report provides a straightforward and convenient mechanism to promote cell infiltration and mediate foreign body response in injectable hydrogels for soft tissue applications. We believe that the readership of Acta Biomaterialia will find the work of interest both for its specific results and general translatability of the findings.
Acute Pancreatitis : Evidence Base Management

S. Pongprasobchai

Abstract:Acute pancreatitis (AP) is an acute inflammatory process of the pancreas, with variable involvement of other regional tissues or remote organ systems. Its overall mortality is approximately 10-20%. There is a wide variation of the disease severity, ranging from mild, self-limiting disease, which is recovered within 3-5 days without morbidity to severe, life-threatening disease which carries mortality rate up to 30-40%. There have been many progresses in the diagnosis, severity staging and management of AP over the last decade and several guidelines have been published over the last few years. However, there are still many controversial issues left that need to be addressed and standardized. This review will summarize the concepts, recent knowledge and advances in the diagnosis, investigation and management of AP. In some issues, particularly those are very controversial, the author’s personal opinions will be noted.
In Vivo Validation of Biological Responses of Bfgf Released from Microspheres Formulated by Blending Poly-Lactide-co-Glycolide and Poly(ethylene Glycol)-Grafted-chitosan in Hamster Cheek Pouch Microcirculatory Models

Christine A. Falabella,Hongliang Jiang,Mary D. Frame,Weiliam Chen

DOI: https://doi.org/10.1163/156856209x444330

2009-01-01

Abstract:Microspheres formulated from blending poly(lactide-co-glycolide) (PLGA) and poly(ethylene glycol)grafted-chitosan (PEG-g-CHN), using a modified in-emulsion-solvent-evaporation method, were investigated for the delivery of protein. A model protein, bovine serum albumin (BSA), was incorporated into the PLGA/PEG-g-CHN microspheres and both initial burst and release kinetics could be modulated by varying the PEG-g-CHN content. Basic fibroblast growth factor (bFGF) was formulated into the microspheres containing 5% PEG-g-CHN and the bFGF contents in the releasates were determined by a receptor-based ELISA with their in vitro bioactivities validated by fibroblast cell culture. The in vivo effect of the bFGF microspheres formulation was evaluated in a hamster cheek pouch model using a 7 day exposure (e. g., before significant vascular remodeling was expected). Using intravital microscopy, the tissue showed no evidence of inflammation with any formulation; deliberate activation of a preconditioning response linked to inflammation was attenuated by BSA microspheres alone. Vasoactive responses (receptor-dependant and independent constriction and dilation) linked to nitric oxide were attenuated, and constriction to endothelin was enhanced in bFGF and not BSA containing microspheres. PLGA/PEG-g-CHN blended microspheres were also demonstrated to be non-inflammatory and non-thrombogenic in vivo by observing the vascular changes in the cheek pouch. In conclusion, the addition of PEG-g-CHN to PLGA microspheres can serve as a sustained delivery vehicle for bFGF and the released protein provides vasoactive changes consistent with chronic bFGF exposure. (C) Koninklijke Brill NV, Leiden, 2009
Enhancing the hydrophilicity of poly(lactic-co-glycolic acid) with serum albumin by creating colloidal drug carriers

Alexandra N. Kovács,Norbert Varga,József Bogner,Ádám Juhász,Edit Csapó

DOI: https://doi.org/10.1016/j.molliq.2024.124271

IF: 6

2024-02-22

Journal of Molecular Liquids

Abstract:Serum protein/copolymer-based nanosized carrier particles with tunable hydrophilic feature was created by a simple preparation method involving the combination of bovine serum albumin (BSA) and poly(lactic-co-glycolic acid) (PLGA). Maintaining the biocompatible nature of the macromolecules, the use of highly toxic solvents was eliminated and a non-ionic surfactant consisting of a natural vitamin E derivative (TPGS) is utilized as stabilizing agent, whose unique triple role is highlighted. In addition to stabilizing the carrier particles, it also functions as an active vitamin E agent and promotes the encapsulation of vitamin D 3 as well by solubilization. Both the BSA-TPGS and the BSA-PLGA interactions have been quantitatively characterized for the first time using several physicochemical and colloid chemistry techniques to produce the nanoscale structure in aqueous medium. The critical micelle concentration (cmc) and the endotherm enthalpy change (Δ mic H= 12.45 ± 0.81 kJ mol −1 ) of the formation of TPGS micelles determined by isothermal titration calorimetry (ITC) was presented as a new data. The prepared nanosized structure has ∼ 200 nm in size with no core–shell structure and the contact angle studies clearly confirm the increasing hydrophilic character of the carriers by the presence of protein and systematic change in the PLGA copolymer ratio. Hydrophobic drug loading can also be controlled by using this combined structure.

chemistry, physical,physics, atomic, molecular & chemical
Liposomes interiorly thickened with thermosensitive nanogels as novel drug delivery systems.

Bei Zhang,Jian Chen,Yi Lu,Jianping Qi,Wei Wu

DOI: https://doi.org/10.1016/j.ijpharm.2013.07.020

IF: 6.51

2013-01-01

International Journal of Pharmaceutics

Abstract:The fundamental structure of liposomes suffers from drawbacks of physical instability. To overcome this problem, the hypothesis of this study was to thicken the liposomal interior by incorporating thermosensitive in situ gel. The so called gelliposomes (GLs) were prepared by a thin-film method using poloxamer solutions as interior aqueous phase. Interior thermosensitive gelation was proved by observation of sustained dissolving of the poloxamer gel after destroying the lipid bilayers with Triton X-100; structural transformation as observed under optical microscopy in a heating–cooling circle also proved the fact of interior gelling. The sol–gel transition temperatures of GLs were in good correlation with those of the bulk poloxamer solution counterparts, which could be easily tailored by adjusting the concentration and ratio of poloxamer 407 (P407) to poloxamer 188 (P188). Membrane anisotropy measurement indicated increased membrane rigidity. In vitro release of the model drug cytosine arabinoside from GLs showed sustained release characteristics for at least one week with typical biphasic kinetics. Study on storage stability and protection against the destroying effect by membrane destroyers indicated improved physical stability in comparison with conventional liposomes. In situ evading of phagocytic uptake by macrophages was observed for GLs, which however should be attributed to the effect of exteriorly adsorbed poloxamers. In conclusion, GLs present distinct characteristics to be used as potential drug delivery systems.
Controlled Liposome Delivery from Chitosan-Based Thermosensitive Hydrogel for Regenerative Medicine

Franco Furlani,Arianna Rossi,Maria Aurora Grimaudo,Giada Bassi,Elena Giusto,Filippo Molinari,Florigio Lista,Monica Montesi,Silvia Panseri

DOI: https://doi.org/10.3390/ijms23020894

IF: 5.6

2022-01-14

International Journal of Molecular Sciences

Abstract:This work describes the development of an injectable nanocomposite system based on a chitosan thermosensitive hydrogel combined with liposomes for regenerative medicine applications. Liposomes with good physicochemical properties are prepared and embedded within the chitosan network. The resulting nanocomposite hydrogel is able to provide a controlled release of the content from liposomes, which are able to interact with cells and be internalized. The cellular uptake is enhanced by the presence of a chitosan coating, and cells incubated with liposomes embedded within thermosensitive hydrogels displayed a higher cell uptake compared to cells incubated with liposomes alone. Furthermore, the gelation temperature of the system resulted to be equal to 32.6 °C; thus, the system can be easily injected in the target site to form a hydrogel at physiological temperature. Given the peculiar performance of the selected systems, the resulting thermosensitive hydrogels are a versatile platform and display potential applications as controlled delivery systems of liposomes for tissue regeneration.

biochemistry & molecular biology,chemistry, multidisciplinary
Injectable liposome-containing click hydrogel microparticles for release of macromolecular cargos

Luisa Lucia Palmese,Paige LeValley,Lina Pradhan,Amanda Lynn Parsons,John Oakey,Matthew Abraham,Suzanne M. D'Addio,April Kloxin,Yingkai Liang,Kristi Kiick

DOI: https://doi.org/10.1039/d3sm01009k

IF: 4.046

2024-01-07

Soft Matter

Abstract:Hydrogel microparticles ranging from 0.1-100μm, referred to as microgels, are attractive for biological applications afforded by their injectability and modularity, which allows facile delivery of mixed populations for tailored combinations of therapeutics. Significant efforts have been made to broaden methods for microgel production including via the materials and chemistries by which they are made. Via droplet-based-microfluidics we have established a method for producing click poly-(ethylene)-glycol (PEG)-based microgels with or without chemically crosslinked liposomes (lipo-microgels) through the Michael-type addition reaction between thiol and either vinyl-sulfone or maleimide groups. Unifom spherical microgels and lipo-microgels were generated with sizes of 74 +/- 16μm and 82 +/- 25μm, respectively, suggesting injectability that was further supported by rheological analyses. Super-resolution confocal microscopy was used to further verify the presence of liposomes within the lipo-microgels and determine their distribution. Atomic force microscopy (AFM) was conducted to compare the mechanical properties and network architecture of bulk hydrogels, microgels, and lipo-microgels. Further, encapsulation and release of model peptide (FITC-Dextran 5kDa) and protein cargo (equine myoglobin) showed sustained release for up to 3 weeks and retention of protein composition and secondary structure, indicating their ability to both protect and release cargos of interest.

polymer science,chemistry, physical,materials science, multidisciplinary,physics
In Vitro Evaluation of Lysozyme-loaded Microspheres in Thermosensitive Methylcellulose-based Hydrogel

Ying Lin,Jiali Sun,Guoqiang Jiang,Jia Zan,Fuxin Ding

DOI: https://doi.org/10.1016/s1004-9541(07)60125-6

2007-01-01

Abstract:Long-term injectable microspheres have some inherent disadvantages such as migration of microspheres from the original site and the burst effect. In order to avoid these problems, microsphere-loaded thermosensitive hydrogel system was designed and expected to achieve a zero-order release of biomolecular drugs in relative high initial drug loadings. Lysozyme, an antibacterial protein usually used to reduce prosthetic valve endocarditis, was selected as the model drug. Poly (DL-lactide-co-glycolide) (PLGA) microspheres, prepared by solvent evaporation method, were employed to encapsulate lysozyme and dispersed into thermosensitive pre-gel solution containing methylcellulose (MC), polyethylene glycol (PEG), sodium citrate (SC), and sodium alginate (SA). The mixture could act as a drug reservoir by performing sol-gel transition rapidly if the temperature was raised from room temperature to 37 degrees C. The in vitro release results showed that the burst effect was avoided due to strengthening of diffusion resistance in the gel. The formulation was able to deliver lysozyme for over 30 days in a nearly zero-order release profile with a rate of 32.8 mu g.d(-1) which exhibits its remarkable potential for effective application in long-term drug delivery.
Bioinspired short peptide hydrogel for versatile encapsulation and controlled release of growth factor therapeutics

Shu Hui Hiew,Jun Kit Wang,Kenrick Koh,Haibo Yang,Abbas Bacha,Junquan Lin,Yun Sheng Yip,Marcus Ivan Gerard Vos,Liyan Chen,Radoslaw M Sobota,Nguan Soon Tan,Chor Yong Tay,Ali Miserez,Radoslaw M. Sobota

DOI: https://doi.org/10.1016/j.actbio.2021.09.023

IF: 10.633

2021-12-01

Acta Biomaterialia

Abstract:A short bioinspired octapeptide, GV8, can self-assemble under mild conditions into biodegradable supramolecular physical hydrogels with high storage modulus and good biocompatibility. GV8 hydrogels can encapsulate both single or multiple macromolecular protein-based therapeutics in a simple one-pot formulation manner, making it a promising candidate to address challenges faced by existing synthetic polymer or peptide hydrogels with complex gelation and drug-encapsulation processes. Alongside its versatility, the hydrogel exhibits concentration-dependent storage modulus and controlled drug-release action. We demonstrate that GV8 hydrogels loaded with adipose-derived mesenchymal stem cells (ADMSC) secretome remain mechanically robust, and exhibit promising potential for wound healing applications by preserving secretome activity while maintaining a constant supply of ADMSC secretome to promote epithelial cell migration. Overall, our work highlights the potential of GV8 peptide hydrogel as a versatile and safe carrier for encapsulation and delivery of macromolecular therapeutics.Statement of Significance: Supramolecular peptide hydrogels are a popular choice for protein-based macromolecular therapeutics delivery; however, despite the development of abundant hydrogel systems, several challenges limit their adaptability and practical applications. GV8 short peptide hydrogel circumvents these drawbacks and demonstrates the ability to function as a versatile growth factor (GF) encapsulant. It can encapsulate precise concentrations of complex adipose-derived mesenchymal stem cells secretome mixtures with a one-pot formulation approach and perform controlled release of GFs with preserved activity without compromising the self-assembly properties and mechanical properties of the hydrogel's supramolecular network. The significance of GV8 hydrogel lies in its gelation simplicity and versatility to encapsulate and deliver macromolecular therapeutics, thus representing a promising biomaterial for regenerative medicine applications.

engineering, biomedical,materials science, biomaterials
Versatile tissue‐injectable hydrogels capable of the extended hydrolytic release of bioactive protein therapeutics

Eric S. Nealy,Steven J. Reed,Steven M. Adelmund,Barry A. Badeau,Jared A. Shadish,Emily J. Girard,Kenneth Brasel,Fiona J. Pakiam,Andrew J. Mhyre,Jason P. Price,Surojit Sarkar,Vandana Kalia,Cole A. DeForest,James M. Olson

DOI: https://doi.org/10.1002/btm2.10668

2024-04-15

Bioengineering & Translational Medicine

Abstract:Hydrogels are extensively employed in healthcare due to their adaptable structures, high water content, and biocompatibility, with FDA‐approved applications ranging from spinal cord regeneration to local therapeutic delivery. However, clinical hydrogels encounter challenges related to inconsistent therapeutic exposure, unmodifiable release windows, and difficulties in subsurface polymer insertion. Addressing these issues, we engineered injectable, biocompatible hydrogels as a local therapeutic depot, utilizing poly(ethylene glycol) (PEG)‐based hydrogels functionalized with bioorthogonal SPAAC handles for network polymerization and functionalization. Our hydrogel solutions polymerize in situ in a temperature‐sensitive manner, persist in tissue, and facilitate the delivery of bioactive therapeutics in subsurface locations. Demonstrating the efficacy of our approach, recombinant anti‐CD47 monoclonal antibodies, when incorporated into subsurface‐injected hydrogel solutions, exhibited cytotoxic activity against infiltrative high‐grade glioma xenografts in the rodent brain. To enhance the gel's versatility, recombinant protein cargos can undergo site‐specific modification with hydrolysable "azidoester" adapters, allowing for user‐defined release profiles from the hydrogel. Hydrogel‐generated gradients of murine CXCL10, linked to intratumorally injected hydrogel solutions via azidoester linkers, resulted in significant recruitment of CD8+ T‐cells and the attenuation of tumor growth in a "cold" syngeneic melanoma model. This study highlights a highly customizable, hydrogel‐based delivery system for local protein therapeutic administration to meet diverse clinical needs.

engineering, biomedical
Injectable Block Copolymer Hydrogels for Sustained Release of a PEGylated Drug

Lin Yu,Guang Tao Chang,Huan Zhang,Jian Dong Ding

DOI: https://doi.org/10.1016/j.ijpharm.2007.07.026

IF: 6.51

2008-01-01

International Journal of Pharmaceutics

Abstract:The paper employs the spontaneous physical gelling property of a biodegradable polymer in water to prepare an injectable sustained release carrier for a PEGylated drug. A series of thermogelling PLGA-PEG-PLGA triblock copolymers were synthesized. The PEGylated camptothecin (CPT) was also prepared and employed as the model of a PEGylated drug, and the solubility of this hydrophobic drug was significantly enhanced to over 150mg/mL. The model drug was completely entrapped into the polymeric hydrogel, and the sustained release lasted for 1 month. The mechanism of the sustained release was diffusion-controlled at the first stage and then was the combination of diffusion and degradation at the late stage. In vivo anti-tumor tests in mice further confirmed the efficacy of the model PEGylated drug released from the hydrogel. This work also revealed the specificity of the PEGylated drug in such a kind of carrier systems by decreasing the critical gelling temperature and increasing the viscosity of the sol. Due to the very convenient drug formulation and highly tunable release rate, an injectable carrier platform for PEGylated drugs is thus set up.
Sustained Release of Doxorubicin from a Thermosensitive Hydrogel

Lin Yu,Tianyuan Ci,Shuchun Zhou,Jiandong Ding

DOI: https://doi.org/10.1016/j.jconrel.2013.08.110

IF: 11.467

2013-01-01

Journal of Controlled Release

Abstract:PLGA (poly(lactic-co-glycolic) acid)-PEG (polyethylene glycol)-PLGA synthesis conditions have an impact on the physicochemical features of the copolymer and its usefulness as biomaterial. This study reports on an analysis of the composition and structural properties of PLGA-PEG-PLGA copolymers applying a variety of analytical techniques. Viscoelastic properties and particularly the temperature-responsive behavior of PLGA-PEG-PLGA showed a marked dependence on copolymer structural features. Physicochemical and biological properties, such as bioadhesion, biocompatibility and cell viability, of the raw copolymers and their gels were also evaluated. The most promising copolymer was chosen to formulate the osteoinductive protein bone morphogenetic protein-2 (125I-BMP-2), and the ability of its gels to sustain the release both in vitro and in vivo was monitored in situ using a gamma counter. In vitro diffusion studies were carried out using a bioinspired set-up that included a biorelevant receptor medium. In vivo release tests after implantation in a critical-size calvarial defect model showed an important burst, but then the release fitted well to the square-root kinetics. Importantly, the release rate constants recorded in vitro and in vivo matched each other suggesting close in vitro–in vivo correlation. Overall, the information gathered opens new perspectives in the biomedical application of these temperature-sensitive materials.
A rhodanine derivative CCR-11 inhibits bacterial proliferation by inhibiting the assembly and GTPase activity of FtsZ.

Parminder Singh,Bhavya Jindal,A. Surolia,D. Panda

DOI: https://doi.org/10.1021/BI201813U

IF: 3.321

2012-06-28

Biochemistry

Abstract:A perturbation of FtsZ assembly dynamics has been shown to inhibit bacterial cytokinesis. In this study, the antibacterial activity of 151 rhodanine compounds was assayed using Bacillus subtilis cells. Of 151 compounds, eight strongly inhibited bacterial proliferation at 2 μM. Subsequently, we used the elongation of B. subtilis cells as a secondary screen to identify potential FtsZ-targeted antibacterial agents. We found that three compounds significantly increased bacterial cell length. One of the three compounds, namely, CCR-11 [(E)-2-thioxo-5-({[3-(trifluoromethyl)phenyl]furan-2-yl}methylene)thiazolidin-4-one], inhibited the assembly and GTPase activity of FtsZ in vitro. CCR-11 bound to FtsZ with a dissociation constant of 1.5 ± 0.3 μM. A docking analysis indicated that CCR-11 may bind to FtsZ in a cavity adjacent to the T7 loop and that short halogen-oxygen, H-bonding, and hydrophobic interactions might be important for the binding of CCR-11 with FtsZ. CCR-11 inhibited the proliferation of B. subtilis cells with a half-maximal inhibitory concentration (IC(50)) of 1.2 ± 0.2 μM and a minimal inhibitory concentration of 3 μM. It also potently inhibited proliferation of Mycobacterium smegmatis cells. Further, CCR-11 perturbed Z-ring formation in B. subtilis cells; however, it neither visibly affected nucleoid segregation nor altered the membrane integrity of the cells. CCR-11 inhibited HeLa cell proliferation with an IC(50) value of 18.1 ± 0.2 μM (∼15 × IC(50) of B. subtilis cell proliferation). The results suggested that CCR-11 inhibits bacterial cytokinesis by inhibiting FtsZ assembly, and it can be used as a lead molecule to develop FtsZ-targeted antibacterial agents.
Cell‐derived Vesicles with Increased Stability and On‐Demand Functionality by Equipping their Membrane with a Cross‐linkable Copolymer

Xinan Huang,Dimitri Hürlimann,Dalin Wu,Michal Skowicki,Ionel Adrian Dinu,Eric R. Dufresne,Cornelia G. Palivan,Hendrik. T. Spanke

DOI: https://doi.org/10.1002/adhm.202202100

IF: 10

2022-10-10

Advanced Healthcare Materials

Abstract:Cell‐derived vesicles retain the cytoplasm and much of the native cell membrane composition. Therefore, they are attractive for investigations of membrane biophysics, drug delivery systems, and complex molecular factories. However, their fragility and aggregation limit their applications. Here, we enhance the mechanical properties and stability of giant plasma membrane vesicles (GPMVs) by decorating them with a specifically designed diblock copolymer, cholesteryl‐poly[2‐aminoethyl methacrylate‐b‐poly(ethylene glycol) methyl ether acrylate]. When cross‐linked, this polymer brush enhanced the stability of the GPMVs. Furthermore, the pH‐responsiveness of the copolymer layer allows for a controlled cargo loading/release, which may enable various bio‐applications. Importantly, the cross‐linked‐copolymer GPMVs are not cytotoxic and preserve in vitro membrane integrity and functionality. This effective strategy to equip the cell‐derived vesicles with stimuli‐responsive cross‐linkable copolymers is expected to open a new route to the stabilization of natural membrane systems and overcome barriers to bio‐medical applications. This article is protected by copyright. All rights reserved

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
Sodium alginate/polyacrylic acid hydrogel composite, potential carrier for fibroblast growth factor1 (FGF1) delivery

Mahsa Mollapour Sisakht,Fatemeh Gholizadeh,Zahra Shahravi,Yasaman Kiani Doust-Vaghe,Mohammad Ali Nilforoushzadeh,Mohammad Amir Amirkhani

DOI: https://doi.org/10.1002/cbdv.202401738

2024-09-29

Chemistry & Biodiversity

Abstract:Fibroblast growth factor1 is a powerful signaling molecule that plays a critical role in injury repair of diverse tissue by stimulating cell growth and angiogenesis. FGF1 has significant role in the cell fate and regulating inflammation with short half‐life and poor in vivo stability. The encapsulation of the growth factor in the hydrogel led to peptide protect from the degradation and/or immune recognition and enable controlled drug delivery over a longer period of time. The aim of this study is to develop and evaluate a hydrogel carrier with adjustable release rate while maintaining bioactivity of FGF1. Here we describe an optimal ratio of sodium alginate and polyacrylic acid without additional cross linker containing FGF1 with the potential of sustained release to be used as a therapeutic agent. The carrier was characterized by FTIR, contact angel and swelling ratio and then variety of FGF1 concentration tested to find the optimum release. The activity of FGF1 after release from the hydrogel was confirmed by ELISA and Western blot. This hydrogel is able to deliver growth factors by restricting the essential proteins within the matrix to prevent rapid proteolysis and explosive release and is therefore widely applicable.

chemistry, multidisciplinary,biochemistry & molecular biology
Dual Network Hydrogels Based on PRP and SA Promote the Retention Rate and Vascularization of Transplanted Fat

Huichen Li,Han Peng,Jiezhang Tang,Mengmeng Hou,Baoyan Liang,Yun Zhu,Yi Cheng,Lihua Yang,Zhaoxiang Zhang,Chenggang Yi

DOI: https://doi.org/10.1007/s00266-023-03783-4

IF: 2.708

2024-01-12

Aesthetic Plastic Surgery

Abstract:Autologous adipose tissue often experiences ischemia and hypoxia after transplantation, leading to low retention rates and unstable operative impacts due to necrotic absorption. Platelet-rich plasma (PRP) can enhance fat regeneration and increase the fat retention rate after transplantation. However, the quick release of growth factors (GFs) in PRP decreases therapeutic efficiency. This study aimed to achieve a slow release of PRP to promote fat retention.

surgery
A New Injectable Thermogelling Material: Methoxy Poly(Ethylene Glycol)-Poly(Sebacic Acid-D,L-Lactic Acid)-Methoxy Poly(Ethylene Glycol) Triblock Co-Polymer

Yinglei Zhai,Liandong Deng,Jinfeng Xing,Yu Liu,Qiang Zhang,Anjie Dong

DOI: https://doi.org/10.1163/156856209x444349

2009-01-01

Journal of Biomaterials Science Polymer Edition

Abstract:A novel injectable thermogelling poly(ester-anhydride) co-polymer, methoxy poly(ethylene glycol) poly(sebacic acid-D,L-lactic acid)-methoxy poly(ethylene glycol) (mPEG-poly(SA-LA)-mPEG) triblock co-polymer, was prepared by melt-condensation polymerization. The synthesized triblock co-polymer was characterized by FT-IR and H-1-NMR. The aqueous solutions of mPEG-poly(SA-LA)-mPEG underwent sol-gel precipitation transition when the temperature was increased from 20 to 70 degrees C, depending on the concentration of the polymer. 5-FU, as the model drug, was mixed into the gel in a low-viscous sol state at room temperature. About 63 wt% of the loaded 5-FU could be released in vitro from the gel over 72 h at 37 degrees C. Subcutaneous injection of 25 wt% mPEG-poly(SA-LA)-mPEG aqueous solution resulted in the formation of a in situ gel depot in a rat model, which sustained for longer time than that of Pluronic F-127 aqueous solution. The biodegradable thermogelling mPEG-poly(SA-LA)-mPEG triblock co-polymer is believed to be a promising candidate for drug-delivery applications. (C) Koninklijke Brill NV, Leiden, 2009
[Surgical treatment of type I dissecting aneurysm combined with annuloaortic ectasia].

T. Goto,K. Ogawa,H. Tsuruta,S. Yamamoto,M. Nakao,S. Yamada,H. Yoshida

1984-12-01

Abstract:
Biological and thermodynamic stabilization of lipid-based delivery systems through natural biopolymers; controlled release and molecular dynamics simulations

Sara Safaeian Laein,Iman Katouzian,M R Mozafari,Amir Farnudiyan-Habibi,Zahra Akbarbaglu,Mohammad Reza Shadan,Khashayar Sarabandi

DOI: https://doi.org/10.1080/10408398.2023.2191281

Abstract:Nowadays, the use of lipid-based nanocarriers for the targeted and controlled delivery of a variety of hydrophobic and hydrophilic bioactive-compounds and drugs has increased significantly. However, challenges such as thermodynamic instability, oxidation, and degradation of lipid membranes, as well as the unintended release of loaded compounds, have limited the use of these systems in the food and pharmaceutical industries. Therefore, the present study reviews the latest achievements in evaluating the characteristics, production methods, challenges, functional, and biological stabilization strategies of lipid-based carriers (including changes in formulation composition, structural modification, membrane-rigidity, and finally monolayer or multilayer coating with biopolymers) in different conditions, as well as molecular dynamics simulations. The scientists' findings indicate the effect of natural biopolymers (such as chitosan, calcium alginate, pectin, dextran, xanthan, caseins, gelatin, whey-proteins, zein, and etc.) in modifying the external structure of lipid-based carriers, improving thermodynamic stability and resistance of membranes to physicochemical and mechanical tensions. However, depending on the type of bioactive compound as well as the design and production goals of the delivery-system, selecting the appropriate biopolymer has a significant impact on the stability of vesicles and maintaining the bioaccessibility of the loaded-compounds due to the stresses caused by the storage-conditions, formulation, processing and gastrointestinal tract.
A Green Approach to Producing Polymer Microparticles for Local Sustained Release of Flavopiridol

Matthew J. Owen,Jasper H. N. Yik,Congwang Ye,Brianca Netto,Dominik R. Haudenschild,Gang-yu Liu

DOI: https://doi.org/10.1007/s40242-021-1262-8

IF: 3.1

2021-08-20

Chemical Research in Chinese Universities

Abstract:Poly(lactic-co-glycolic acid)(PLGA) microparticles represent an important class of materials used for drug delivery. Current synthesis frequently uses conventional emulsion, where dichloromethane(DCM) is used as the organic phase solvent. Due to the health and environmental toxicity of DCM and its slow degradation, this work replaces DCM with a greener solvent, dimethyl carbonate(DMC). To attain narrow distribution of PLGA particle size, microfluidic flow focusing was chosen over conventional emulsion. This new approach successfully produced PLGA microparticles encapsulated with flavopiridol, a kinase inhibitor. These particles exhibit sustained release profile more desirable than the conventional counterparts. The cytotoxicity and activity tests have demonstrated high biocompatibility and efficacy of these PLGA particles. The high sustainability is also evaluated using simple E-Factor(sEF) and complete E-Factor(cEF). The lower health and environmental toxicities of DMC than DCM are evidenced by approximately one order of magnitude higher in lethal dose, i. e., 50%(LD50) values in rat, 5-fold faster degradation rate, and 30% higher GlaxoSmithKline(GSK) combined greenness value. The approach reported in this work shall provide a new and green means for drug delivery in general. The products enable local sustained delivery of flavopiridol for prevention of post-traumatic osteoarthritis, and anti-cancer therapy.

chemistry, multidisciplinary

A Constructive Algorithm for Wavelet Neural Networks

Injectable, porous, biohybrid hydrogels incorporating decellularized tissue components for soft tissue applications.

Acute Pancreatitis : Evidence Base Management

In Vivo Validation of Biological Responses of Bfgf Released from Microspheres Formulated by Blending Poly-Lactide-co-Glycolide and Poly(ethylene Glycol)-Grafted-chitosan in Hamster Cheek Pouch Microcirculatory Models

Enhancing the hydrophilicity of poly(lactic-co-glycolic acid) with serum albumin by creating colloidal drug carriers

Liposomes interiorly thickened with thermosensitive nanogels as novel drug delivery systems.

Controlled Liposome Delivery from Chitosan-Based Thermosensitive Hydrogel for Regenerative Medicine

Injectable liposome-containing click hydrogel microparticles for release of macromolecular cargos

In Vitro Evaluation of Lysozyme-loaded Microspheres in Thermosensitive Methylcellulose-based Hydrogel

Bioinspired short peptide hydrogel for versatile encapsulation and controlled release of growth factor therapeutics

Versatile tissue‐injectable hydrogels capable of the extended hydrolytic release of bioactive protein therapeutics

Injectable Block Copolymer Hydrogels for Sustained Release of a PEGylated Drug

Sustained Release of Doxorubicin from a Thermosensitive Hydrogel

A rhodanine derivative CCR-11 inhibits bacterial proliferation by inhibiting the assembly and GTPase activity of FtsZ.

Cell‐derived Vesicles with Increased Stability and On‐Demand Functionality by Equipping their Membrane with a Cross‐linkable Copolymer

Sodium alginate/polyacrylic acid hydrogel composite, potential carrier for fibroblast growth factor1 (FGF1) delivery

Dual Network Hydrogels Based on PRP and SA Promote the Retention Rate and Vascularization of Transplanted Fat

A New Injectable Thermogelling Material: Methoxy Poly(Ethylene Glycol)-Poly(Sebacic Acid-D,L-Lactic Acid)-Methoxy Poly(Ethylene Glycol) Triblock Co-Polymer

[Surgical treatment of type I dissecting aneurysm combined with annuloaortic ectasia].

Biological and thermodynamic stabilization of lipid-based delivery systems through natural biopolymers; controlled release and molecular dynamics simulations

A Green Approach to Producing Polymer Microparticles for Local Sustained Release of Flavopiridol